Joshua Burshtein is a Dermatology physician affiliated with University of Illinois Urbana-Champaign. OpenAlex indexes 90 publications with 323 citations (h-index 11).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1801 W Taylor St
Chicago, IL 606124795
Telephone
312-996-8666Provider last certified this registry record 2 Aug 2024.
Industry payments
27 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Janssen Biotech, Inc.Program year20259 payments
- SUN PHARMACEUTICAL INDUSTRIES INC.Program year20257 payments
- ABBVIE INC.Program year20256 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
41%Azole Antifungal28%Ketoconazole100%Part D≥18 patientsLincosamide Antibacterial13%Clindamycin Phosphate100%Part D<11 patientsDermatology
41%Corticosteroid41%Triamcinolone Acetonide100%Part D≥27 patientsSensory organs
18%Corticosteroid18%Clobetasol Propionate100%Part D≥13 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- The role and risks of systemic corticosteroids in atopic dermatitis: an expert consensus
Archives of Dermatological Research
2026 - Emerging pharmacotherapies and regenerative solutions for promoting hair growth for androgenetic alopecia
Frontiers in Pharmacology
2026 - Advances in the noninvasive diagnosis of melanoma—40 years beyond the ABCDs
CA A Cancer Journal for Clinicians
2026 - Remibrutinib: Insights Into Its Mechanism of Action and Use for Dermatologic Conditions
Journal of Drugs in Dermatology
2026 - Artificial Intelligence in Dermatology: A Comprehensive Review of Approved Applications, Clinical Implementation, and Future Directions
International Journal of Dermatology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Issam Moussa, MD
University of Illinois Urbana-Champaign
Ali Alaraj, MD
University of Illinois Urbana-Champaign
Thasarat Vajaranant, MD
University of Illinois Urbana-Champaign
Janet Jokela, MD
University of Illinois Urbana-Champaign
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”